文献速递心力衰竭与心肌病血脂与心血管预防

精英足球运动员新冠感染后新发12导联心电图改变的患病率与诊断意义

Prevalence and diagnostic significance of de-novo 12-lead ECG changes after COVID-19 infection in elite soccer players.
PubMed 文献 · Heart · 2023-05-26

这项多中心观察研究纳入511名新冠感染后的足球运动员,发现3%出现新发心电图改变,其中88%经心脏磁共振诊断为心脏炎症。新发心电图改变者心脏症状更常见且持续时间更长,在无症状运动员中额外检出心脏炎症的贡献为20%。

要点

  • 新冠感染后3%的运动员出现新发心电图改变,其中88%存在心脏炎症。
  • 新发心电图改变者心脏症状比例更高(71% vs 12%)。
  • 无症状运动员中新发心电图改变对心脏炎症的额外检出率为20%。

核心结论

  • 3%的运动员新冠感染后出现新发心电图改变,其中88%被诊断为心脏炎症。
  • 多数受累运动员有心脏症状,但新发心电图改变在20%的无症状运动员中贡献了心脏炎症的诊断。

研究设计与样本

  • 多中心观察研究,2020年3月至2022年5月连续纳入新冠感染的运动员。
  • 共纳入511名足球运动员,中位年龄21岁(IQR 18-26岁)。
  • 出现新发心电图改变者接受心脏磁共振扫描;一家俱乐部对所有球员(n=30)强制进行心脏磁共振扫描。

主要发现

  • 17名(3%)运动员出现新发心电图改变,包括下壁和侧壁导联T波振幅减低(n=5)、下壁导联T波振幅减低(n=4)、侧壁导联T波振幅减低(n=4)、下壁T波倒置(n=7)和ST段压低(n=2)。
  • 15名(88%)新发心电图改变运动员显示心脏炎症后遗证据。
  • 所有30名强制接受心脏磁共振扫描的运动员结果正常。
  • 新发心电图改变运动员心脏症状患病率更高(71% vs 12%,p<0.0001),症状中位持续时间更长(5天,IQR 3-10) vs (2天,IQR 1-3,p<0.001)。
  • 在无症状运动员中,新发心电图改变检测心脏炎症的额外贡献为20%。

临床怎么用

  • 新冠感染后运动员应进行心电图筛查,新发心电图改变提示需进一步心脏磁共振评估心脏炎症。
  • 无症状运动员中新发心电图改变仍有一定比例的心脏炎症检出,不应忽视。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIM: The efficacy of pre-COVID-19 and post-COVID-19 infection 12-lead ECGs for identifying athletes with myopericarditis has never been reported. We aimed to assess the prevalence and significance of de-novo ECG changes following COVID-19 infection. METHODS: In this multicentre observational study, between March 2020 and May 2022, we evaluated consecutive athletes with COVID-19 infection. Athletes exhibiting de-novo ECG changes underwent cardiovascular magnetic resonance (CMR) scans. One club mandated CMR scans for all players (n=30) following COVID-19 infection, despite the absence of cardiac symptoms or de-novo ECG changes. RESULTS: 511 soccer players (median age 21 years, IQR 18-26 years) were included. 17 (3%) athletes demonstrated de-novo ECG changes, which included reduction in T-wave amplitude in the inferior and lateral leads (n=5), inferior leads (n=4) and lateral leads (n=4); inferior T-wave inversion (n=7); and ST-segment depression (n=2). 15 (88%) athletes with de-novo ECG changes revealed evidence of inflammatory cardiac sequelae. All 30 athletes who underwent a mandatory CMR scan had normal findings. Athletes revealing de-novo ECG changes had a higher prevalence of cardiac symptoms (71% vs 12%, p<0.0001) and longer median symptom duration (5 days, IQR 3-10) compared with athletes without de-novo ECG changes (2 days, IQR 1-3, p<0.001). Among athletes without cardiac symptoms, the additional yield of de-novo ECG changes to detect cardiac inflammation was 20%. CONCLUSIONS: 3% of athletes demonstrated de-novo ECG changes post COVID-19 infection, of which 88% were diagnosed with cardiac inflammation. Most affected athletes exhibited cardiac symptoms; however, de-novo ECG changes contributed to a diagnosis of cardiac inflammation in 20% of athletes without cardiac symptoms.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Bhatia RT, Malhotra A, MacLachlan H, et al. Prevalence and diagnostic significance of de-novo 12-lead ECG changes after COVID-19 infection in elite soccer players. Heart. 2023. PMID: 37039240. doi:10.1136/heartjnl-2022-322211

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。